| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.92 | 0.003 | 0.92 | Aldehyde oxidase inhibitor | 0.248 0.083 CID_70500973 | ||
| 0.671 | 0.003 | 0.671 | Calcium channel L-type activator | 0.488 0.032 CID_70500973 | ||
| 0.631 | 0.004 | 0.631 | Peroxidase inhibitor | |||
| 0.631 | 0.005 | 0.631 | Superoxide dismutase inhibitor | |||
| 0.623 | 0.005 | 0.623 | GABA C receptor rho-3 antagonist | |||
| 0.615 | 0.003 | 0.615 | Alcohol oxidase inhibitor | 0.061 0.035 CID_70500973 | ||
| 0.61 | 0.017 | 0.768 | Cholesterol antagonist | 0.768 0.005 CID_70500973 | CID_70500973 | |
| 0.577 | 0.017 | 0.577 | 5 Hydroxytryptamine release stimulant | 0.418 0.042 CID_70500973 | ||
| 0.556 | 0.003 | 0.556 | Estrogen receptor beta antagonist | |||
| 0.59 | 0.038 | 0.59 | Caspase 9 stimulant | 0.55 0.045 CID_70500973 | ||
| 0.527 | 0.004 | 0.527 | Estrogen antagonist | 0.121 0.054 CID_70500973 | ||
| 0.536 | 0.022 | 0.598 | 5 Hydroxytryptamine release inhibitor | 0.598 0.011 CID_70500973 | CID_70500973 | |
| 0.509 | 0.004 | 0.509 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.517 | 0.015 | 0.691 | Free radical scavenger | 0.691 0.005 CID_70500973 | CID_70500973 | |
| 0.5 | 0.005 | 0.5 | Calcium channel activator | 0.32 0.073 CID_70500973 | ||
| 0.511 | 0.019 | 0.749 | Antioxidant | 0.749 0.005 CID_70500973 | CID_70500973 | |
| 0.488 | 0.008 | 0.488 | Tubulin antagonist | |||
| 0.478 | 0.006 | 0.768 | Amylase inhibitor | 0.768 0.002 CID_70500973 | CID_70500973 | |
| 0.508 | 0.039 | 0.508 | 15-Lipoxygenase inhibitor | |||
| 0.466 | 0.006 | 0.677 | Alpha-N-acetylglucosaminidase inhibitor | 0.677 0.003 CID_70500973 | CID_70500973 | |
| 0.447 | 0.008 | 0.447 | 5 Hydroxytryptamine uptake stimulant | 0.197 0.158 CID_70500973 | ||
| 0.472 | 0.04 | 0.562 | Histamine release inhibitor | 0.562 0.014 CID_70500973 | CID_70500973 | |
| 0.453 | 0.024 | 0.453 | Interleukin antagonist | 0.169 0.104 CID_70500973 | ||
| 0.437 | 0.018 | 0.526 | Interleukin 2 agonist | 0.526 0.005 CID_70500973 | CID_70500973 | |
| 0.433 | 0.026 | 0.656 | Vasodilator, coronary | 0.656 0.005 CID_70500973 | CID_70500973 | |
| 0.485 | 0.079 | 0.683 | Apoptosis agonist | 0.683 0.034 CID_70500973 | CID_70500973 | |
| 0.431 | 0.032 | 0.431 | 12-Lipoxygenase inhibitor | |||
| 0.412 | 0.023 | 0.412 | Amyloid beta aggregation inhibitor | 0.203 0.076 CID_70500973 | ||
| 0.483 | 0.095 | 0.843 | Antiinflammatory | 0.843 0.01 CID_70500973 | CID_70500973 | |
| 0.408 | 0.021 | 0.408 | Insulysin inhibitor | |||
| 0.406 | 0.022 | 0.406 | Antimitotic | 0.186 0.092 CID_70500973 | ||
| 0.391 | 0.008 | 0.391 | Cyclooxygenase 1 inhibitor | 0.195 0.036 CID_70500973 | ||
| 0.415 | 0.034 | 0.415 | Lipoxygenase inhibitor | |||
| 0.408 | 0.028 | 0.442 | Hypoxia-inducible factor 1 alpha inhibitor | 0.442 0.021 CID_70500973 | CID_70500973 | |
| 0.432 | 0.057 | 0.726 | Transcription factor NF kappa B inhibitor | 0.726 0.018 CID_70500973 | CID_70500973 | |
| 0.387 | 0.021 | 0.54 | Interleukin agonist | 0.54 0.007 CID_70500973 | CID_70500973 | |
| 0.434 | 0.073 | 0.434 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.364 | 0.004 | 0.364 | Estrogen agonist | 0.106 0.016 CID_70500973 | ||
| 0.365 | 0.006 | 0.365 | GABA C receptor agonist | 0.088 0.081 CID_70500973 | ||
| 0.36 | 0.006 | 0.36 | Cystathionine beta-synthase inhibitor | 0.297 0.01 CID_70500973 | ||
| 0.357 | 0.004 | 0.357 | Alpha tubulin antagonist | |||
| 0.368 | 0.017 | 0.622 | Non-steroidal antiinflammatory agent | 0.622 0.004 CID_70500973 | CID_70500973 | |
| 0.349 | 0.003 | 0.349 | Creatine kinase inhibitor | |||
| 0.362 | 0.019 | 0.362 | Dual specificity phosphatase 3 inhibitor | |||
| 0.37 | 0.028 | 0.37 | Pyruvate kinase inhibitor | |||
| 0.437 | 0.1 | 0.69 | Alpha-glucosidase inhibitor | 0.69 0.035 CID_70500973 | CID_70500973 | |
| 0.341 | 0.004 | 0.341 | Alcohol dehydrogenase inhibitor | 0.255 0.007 CID_70500973 | ||
| 0.344 | 0.008 | 0.344 | Interleukin 1 antagonist | 0.16 0.051 CID_70500973 | ||
| 0.338 | 0.005 | 0.338 | Porphobilinogen synthase inhibitor | |||
| 0.334 | 0.004 | 0.334 | MAP kinase kinase 4 inhibitor | 0.141 0.083 CID_70500973 | ||
| 0.335 | 0.007 | 0.335 | Interleukin 1b antagonist | 0.187 0.023 CID_70500973 | ||
| 0.327 | 0.005 | 0.327 | Farnesoid X receptor antagonist | 0.135 0.074 CID_70500973 | ||
| 0.374 | 0.056 | 0.779 | Antithrombotic | 0.779 0.005 CID_70500973 | CID_70500973 | |
| 0.326 | 0.009 | 0.326 | Aldehyde dehydrogenase inhibitor | 0.27 0.015 CID_70500973 | ||
| 0.339 | 0.023 | 0.339 | Dual specificity phosphatase inhibitor | |||
| 0.318 | 0.002 | 0.318 | DOPA decarboxylase inhibitor | 0.128 0.037 CID_70500973 | ||
| 0.322 | 0.01 | 0.322 | NADPH oxidase inhibitor | 0.246 0.022 CID_70500973 | ||
| 0.314 | 0.003 | 0.314 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.337 | 0.026 | 0.337 | RNA-directed DNA polymerase inhibitor | 0.266 0.041 CID_70500973 | ||
| 0.375 | 0.064 | 0.375 | Vasodilator, peripheral | 0.354 0.072 CID_70500973 | ||
| 0.316 | 0.009 | 0.316 | Succinate dehydrogenase inhibitor | 0.171 0.079 CID_70500973 | ||
| 0.319 | 0.014 | 0.326 | Neurotrophic factor enhancer | 0.326 0.012 CID_70500973 | CID_70500973 | |
| 0.313 | 0.01 | 0.466 | UDP-glucose 4-epimerase inhibitor | 0.466 0.003 CID_70500973 | CID_70500973 | |
| 0.341 | 0.04 | 0.758 | Hypoglycemic | 0.758 0.004 CID_70500973 | CID_70500973 | |
| 0.305 | 0.005 | 0.305 | Uric acid excretion stimulant | 0.269 0.005 CID_70500973 | ||
| 0.359 | 0.059 | 0.359 | Streptokinase A inhibitor | |||
| 0.303 | 0.005 | 0.314 | Mannose-6-phosphate isomerase inhibitor | 0.314 0.005 CID_70500973 | CID_70500973 | |
| 0.308 | 0.01 | 0.46 | Hexokinase inhibitor | 0.46 0.003 CID_70500973 | CID_70500973 | |
| 0.305 | 0.01 | 0.305 | Nitric-oxide synthase stimulant | 0.3 0.011 CID_70500973 | ||
| 0.3 | 0.006 | 0.3 | Carbonic anhydrase VI inhibitor | 0.131 0.026 CID_70500973 | ||
| 0.314 | 0.02 | 0.314 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.238 0.048 CID_70500973 | ||
| 0.307 | 0.016 | 0.307 | Cyclooxygenase inhibitor | 0.175 0.054 CID_70500973 | ||
| 0.289 | 0.004 | 0.289 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.335 | 0.052 | 0.335 | Aryl hydrocarbon receptor agonist | |||
| 0.29 | 0.007 | 0.29 | Adenylate kinase inhibitor | 0.23 0.012 CID_70500973 | ||
| 0.284 | 0.005 | 0.284 | Beta tubulin antagonist | |||
| 0.283 | 0.004 | 0.283 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.318 | 0.043 | 0.852 | Angiogenesis stimulant | 0.852 0.003 CID_70500973 | CID_70500973 | |
| 0.329 | 0.054 | 0.329 | Sodium/bile acid cotransporter inhibitor | 0.225 0.156 CID_70500973 | ||
| 0.294 | 0.021 | 0.469 | Interferon gamma antagonist | 0.469 0.008 CID_70500973 | CID_70500973 | |
| 0.279 | 0.007 | 0.279 | Histidine decarboxylase inhibitor | |||
| 0.29 | 0.019 | 0.573 | Monophenol monooxygenase inhibitor | 0.573 0.005 CID_70500973 | CID_70500973 | |
| 0.298 | 0.033 | 0.298 | Anesthetic general | 0.276 0.04 CID_70500973 | ||
| 0.33 | 0.066 | 0.367 | Caspase 3 stimulant | 0.367 0.054 CID_70500973 | CID_70500973 | |
| 0.283 | 0.021 | 0.398 | Lipid peroxidase inhibitor | 0.398 0.01 CID_70500973 | CID_70500973 | |
| 0.265 | 0.005 | 0.265 | Estrogen receptor alpha antagonist | |||
| 0.279 | 0.021 | 0.279 | Insulin sensitizer | 0.273 0.024 CID_70500973 | ||
| 0.3 | 0.043 | 0.309 | Psychostimulant | 0.309 0.04 CID_70500973 | CID_70500973 | |
| 0.281 | 0.024 | 0.465 | Melanin inhibitor | 0.465 0.008 CID_70500973 | CID_70500973 | |
| 0.317 | 0.064 | 0.433 | Spasmolytic | 0.433 0.034 CID_70500973 | CID_70500973 | |
| 0.262 | 0.01 | 0.262 | GABA C receptor rho-2 antagonist | |||
| 0.275 | 0.023 | 0.275 | Tumour necrosis factor antagonist | |||
| 0.258 | 0.008 | 0.258 | Toll-Like receptor 2 antagonist | 0.125 0.073 CID_70500973 | ||
| 0.294 | 0.044 | 0.445 | Cyclic AMP phosphodiesterase inhibitor | 0.445 0.011 CID_70500973 | CID_70500973 | |
| 0.289 | 0.041 | 0.289 | Gastrin inhibitor | 0.254 0.075 CID_70500973 | ||
| 0.256 | 0.012 | 0.256 | Ferrochelatase inhibitor | |||
| 0.336 | 0.093 | 0.336 | Calpain 2 inhibitor | |||
| 0.248 | 0.006 | 0.248 | Arachidonic acid antagonist | 0.207 0.026 CID_70500973 | ||
| 0.254 | 0.013 | 0.254 | Interleukin 4 antagonist | 0.181 0.029 CID_70500973 | ||
| 0.254 | 0.013 | 0.412 | ATPase inhibitor | 0.412 0.004 CID_70500973 | CID_70500973 | |
| 0.262 | 0.023 | 0.262 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.245 | 0.007 | 0.454 | Triose-phosphate isomerase inhibitor | 0.454 0.003 CID_70500973 | CID_70500973 | |
| 0.273 | 0.035 | 0.273 | P-glycoprotein inhibitor | 0.233 0.047 CID_70500973 | ||
| 0.249 | 0.016 | 0.249 | 5-Lipoxygenase inhibitor | |||
| 0.271 | 0.038 | 0.362 | DNA methyltransferase I inhibitor | 0.362 0.012 CID_70500973 | CID_70500973 | |
| 0.245 | 0.013 | 0.358 | Xanthine oxidase inhibitor | 0.358 0.005 CID_70500973 | CID_70500973 | |
| 0.252 | 0.02 | 0.252 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.239 | 0.007 | 0.351 | Photosensitizer | 0.351 0.004 CID_70500973 | CID_70500973 | |
| 0.24 | 0.013 | 0.24 | Nav1.1 sodium channel blocker | |||
| 0.267 | 0.04 | 0.392 | DNA methylase inhibitor | 0.392 0.011 CID_70500973 | CID_70500973 | |
| 0.231 | 0.004 | 0.231 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.246 | 0.019 | 0.246 | Adenylate cyclase inhibitor | 0.155 0.042 CID_70500973 | ||
| 0.229 | 0.003 | 0.229 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.319 | 0.094 | 0.319 | Prostaglandin dehydrogenase inhibitor | |||
| 0.229 | 0.005 | 0.229 | Glutamate decarboxylase inhibitor | |||
| 0.231 | 0.011 | 0.231 | Carbonic anhydrase III inhibitor | 0.125 0.041 CID_70500973 | ||
| 0.223 | 0.008 | 0.223 | Interleukin 8 antagonist | 0.106 0.084 CID_70500973 | ||
| 0.239 | 0.027 | 0.239 | Phospholipase C inhibitor | 0.196 0.047 CID_70500973 | ||
| 0.216 | 0.004 | 0.216 | Glycine receptor agonist | 0.188 0.004 CID_70500973 | ||
| 0.242 | 0.03 | 0.242 | Heat shock protein 90 alpha antagonist | |||
| 0.227 | 0.015 | 0.227 | Carbonic anhydrase XV inhibitor | |||
| 0.236 | 0.025 | 0.236 | Heat shock protein 90 antagonist | |||
| 0.297 | 0.087 | 0.557 | Apoptosis antagonist | 0.557 0.014 CID_70500973 | CID_70500973 | |
| 0.222 | 0.013 | 0.307 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.307 0.006 CID_70500973 | CID_70500973 | |
| 0.215 | 0.01 | 0.215 | GABA C receptor antagonist | |||
| 0.262 | 0.059 | 0.419 | DNA synthesis inhibitor | 0.419 0.019 CID_70500973 | CID_70500973 | |
| 0.233 | 0.034 | 0.233 | Histone acetyltransferase inhibitor | |||
| 0.233 | 0.036 | 0.233 | Protein-tyrosine phosphatase inhibitor | 0.194 0.049 CID_70500973 | ||
| 0.267 | 0.071 | 0.267 | Transcription factor STAT3 inhibitor | |||
| 0.21 | 0.013 | 0.21 | Catalase inhibitor | |||
| 0.21 | 0.017 | 0.21 | CF transmembrane conductance regulator agonist | 0.156 0.065 CID_70500973 | ||
| 0.224 | 0.032 | 0.224 | Phospholipase A2 inhibitor | 0.194 0.046 CID_70500973 | ||
| 0.267 | 0.076 | 0.267 | Transcription factor STAT inhibitor | |||
| 0.2 | 0.01 | 0.404 | NADH dehydrogenase inhibitor | 0.404 0.004 CID_70500973 | CID_70500973 | |
| 0.223 | 0.033 | 0.223 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.202 | 0.013 | 0.202 | Adenylate cyclase stimulant | 0.146 0.07 CID_70500973 | ||
| 0.196 | 0.009 | 0.196 | Keratolytic | |||
| 0.215 | 0.029 | 0.215 | Neurotensin receptor agonist | |||
| 0.195 | 0.01 | 0.195 | Prolactin inhibitor | |||
| 0.196 | 0.015 | 0.196 | Protein kinase C gamma inhibitor | |||
| 0.196 | 0.014 | 0.204 | Mucolytic | 0.204 0.012 CID_70500973 | CID_70500973 | |
| 0.214 | 0.033 | 0.313 | Interleukin 6 antagonist | 0.313 0.013 CID_70500973 | CID_70500973 | |
| 0.206 | 0.026 | 0.206 | DNA polymerase I inhibitor | 0.203 0.027 CID_70500973 | ||
| 0.193 | 0.013 | 0.193 | Pregnane X receptor agonist | |||
| 0.225 | 0.045 | 0.225 | Mcl-1 antagonist | |||
| 0.252 | 0.072 | 0.252 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.184 | 0.005 | 0.184 | Ca2+-transporting ATPase inhibitor | 0.179 0.007 CID_70500973 | ||
| 0.199 | 0.02 | 0.245 | Microtubule formation inhibitor | 0.245 0.01 CID_70500973 | CID_70500973 | |
| 0.188 | 0.01 | 0.188 | GABA C receptor rho-1 antagonist | |||
| 0.231 | 0.057 | 0.512 | Nitric oxide antagonist | 0.512 0.015 CID_70500973 | CID_70500973 | |
| 0.195 | 0.025 | 0.195 | Chelator | |||
| 0.203 | 0.035 | 0.203 | Bone formation stimulant | 0.141 0.066 CID_70500973 | ||
| 0.242 | 0.074 | 0.342 | Antiamyloidogenic | 0.342 0.041 CID_70500973 | CID_70500973 | |
| 0.173 | 0.005 | 0.173 | Estrogen receptor beta agonist | |||
| 0.302 | 0.134 | 0.648 | Antibacterial | 0.648 0.013 CID_70500973 | CID_70500973 | |
| 0.172 | 0.005 | 0.172 | Estrogen receptor alpha agonist | |||
| 0.171 | 0.006 | 0.194 | Glutamate release inhibitor | 0.194 0.005 CID_70500973 | CID_70500973 | |
| 0.18 | 0.016 | 0.18 | Breast cancer-resistant protein inhibitor | |||
| 0.168 | 0.005 | 0.168 | CD45 antagonist | |||
| 0.243 | 0.08 | 0.243 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.246 | 0.085 | 0.246 | Cardiotonic | |||
| 0.191 | 0.031 | 0.195 | Protein-tyrosine phosphatase 1B inhibitor | 0.195 0.031 CID_70500973 | CID_70500973 | |
| 0.162 | 0.004 | 0.162 | Estrogen-related receptor beta agonist | |||
| 0.183 | 0.024 | 0.501 | Expectorant | 0.501 0.004 CID_70500973 | CID_70500973 | |
| 0.161 | 0.003 | 0.161 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.163 | 0.006 | 0.163 | Protein kinase C eta inhibitor | 0.073 0.027 CID_70500973 | ||
| 0.182 | 0.027 | 0.487 | Cyclooxygenase 3 inhibitor | 0.487 0.003 CID_70500973 | CID_70500973 | |
| 0.159 | 0.005 | 0.159 | D-Ala-D-Ala ligase inhibitor | |||
| 0.162 | 0.008 | 0.162 | Ornithine decarboxylase inhibitor | 0.134 0.017 CID_70500973 | ||
| 0.171 | 0.017 | 0.176 | Heat shock protein 70 antagonist | 0.176 0.014 CID_70500973 | CID_70500973 | |
| 0.169 | 0.015 | 0.285 | Phosphofructokinase-1 inhibitor | 0.285 0.006 CID_70500973 | CID_70500973 | |
| 0.176 | 0.023 | 0.176 | 5 Hydroxytryptamine 3A agonist | |||
| 0.24 | 0.086 | 0.268 | DNA damaging | 0.268 0.071 CID_70500973 | CID_70500973 | |
| 0.208 | 0.055 | 0.208 | Growth factor agonist | |||
| 0.176 | 0.028 | 0.176 | Aminopeptidase B inhibitor | |||
| 0.231 | 0.083 | 0.231 | Calpain inhibitor | |||
| 0.192 | 0.044 | 0.369 | NOS3 expression enhancer | 0.369 0.01 CID_70500973 | CID_70500973 | |
| 0.308 | 0.161 | 0.308 | DNA polymerase beta inhibitor | |||
| 0.159 | 0.013 | 0.159 | Macrophage migration inhibitory factor inhibitor | |||
| 0.224 | 0.08 | 0.41 | Hypolipemic | 0.41 0.024 CID_70500973 | CID_70500973 | |
| 0.16 | 0.016 | 0.16 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.156 | 0.012 | 0.156 | CDC25A inhibitor | |||
| 0.225 | 0.082 | 0.225 | Neuropeptide Y2 antagonist | |||
| 0.165 | 0.022 | 0.165 | TRPA1 agonist | 0.1 0.088 CID_70500973 | ||
| 0.154 | 0.011 | 0.156 | Interleukin 12 antagonist | 0.156 0.011 CID_70500973 | CID_70500973 | |
| 0.153 | 0.013 | 0.153 | Histamine N-methyltransferase inhibitor | |||
| 0.213 | 0.074 | 0.213 | MAP kinase kinase 2 inhibitor | |||
| 0.258 | 0.119 | 0.258 | Thyroid hormone antagonist | |||
| 0.299 | 0.161 | 0.299 | DNA directed DNA polymerase inhibitor | |||
| 0.153 | 0.015 | 0.161 | Acetylcholine release stimulant | 0.161 0.011 CID_70500973 | CID_70500973 | |
| 0.146 | 0.009 | 0.146 | GABA aminotransferase inhibitor | 0.126 0.014 CID_70500973 | ||
| 0.172 | 0.035 | 0.172 | MAO A inhibitor | |||
| 0.145 | 0.008 | 0.145 | Bile acid receptor antagonist | 0.104 0.04 CID_70500973 | ||
| 0.139 | 0.003 | 0.139 | Dopamine D5 agonist | |||
| 0.184 | 0.048 | 0.339 | Protein kinase stimulant | 0.339 0.013 CID_70500973 | CID_70500973 | |
| 0.169 | 0.034 | 0.169 | Antibacterial (Helicobacter pylori) | |||
| 0.142 | 0.007 | 0.142 | Elastase 1 inhibitor | |||
| 0.152 | 0.017 | 0.152 | Anabolic | 0.087 0.083 CID_70500973 | ||
| 0.141 | 0.007 | 0.141 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.159 | 0.026 | 0.159 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.155 | 0.023 | 0.443 | Beta glucuronidase inhibitor | 0.443 0.004 CID_70500973 | CID_70500973 | |
| 0.151 | 0.019 | 0.151 | Electrolyte absorption antagonist | |||
| 0.157 | 0.025 | 0.157 | Potassium channel (Ca-activated) activator | |||
| 0.234 | 0.103 | 0.521 | Immunostimulant | 0.521 0.026 CID_70500973 | CID_70500973 | |
| 0.147 | 0.016 | 0.147 | Glutamate dehydrogenase inhibitor | 0.098 0.032 CID_70500973 | ||
| 0.137 | 0.008 | 0.137 | CDC25B inhibitor | |||
| 0.137 | 0.009 | 0.137 | Purinergic P2X1 antagonist | 0.071 0.031 CID_70500973 | ||
| 0.165 | 0.038 | 0.165 | Cholesterol synthesis inhibitor | 0.121 0.064 CID_70500973 | ||
| 0.176 | 0.049 | 0.176 | MAO inhibitor | |||
| 0.131 | 0.004 | 0.131 | Catechol O-methyltransferase inhibitor | |||
| 0.136 | 0.011 | 0.136 | Biliverdin reductase inhibitor | 0.088 0.022 CID_70500973 | ||
| 0.144 | 0.019 | 0.17 | Thioredoxin inhibitor | 0.17 0.012 CID_70500973 | CID_70500973 | |
| 0.168 | 0.043 | 0.168 | Cyclooxygenase 2 inhibitor | 0.109 0.092 CID_70500973 | ||
| 0.156 | 0.033 | 0.156 | Vanilloid 1 agonist | 0.142 0.047 CID_70500973 | ||
| 0.139 | 0.016 | 0.139 | Cyclin B3 inhibitor | |||
| 0.176 | 0.055 | 0.176 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.209 | 0.088 | 0.438 | Peptidyltransferase inhibitor | 0.438 0.005 CID_70500973 | CID_70500973 | |
| 0.244 | 0.123 | 0.244 | Thyroid hormone beta antagonist | |||
| 0.163 | 0.042 | 0.163 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.144 | 0.024 | 0.144 | Protein kinase C delta inhibitor | |||
| 0.125 | 0.005 | 0.125 | Aconitate hydratase inhibitor | |||
| 0.152 | 0.032 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.132 | 0.013 | 0.142 | Aldose reductase inhibitor | 0.142 0.011 CID_70500973 | CID_70500973 | |
| 0.131 | 0.012 | 0.131 | HIV-1 integrase inhibitor | |||
| 0.125 | 0.006 | 0.125 | GABA B receptor agonist | |||
| 0.168 | 0.049 | 0.348 | Cell wall synthesis inhibitor | 0.348 0.008 CID_70500973 | CID_70500973 | |
| 0.142 | 0.024 | 0.142 | Androgen antagonist | |||
| 0.131 | 0.015 | 0.131 | Myeloperoxidase inhibitor | |||
| 0.174 | 0.058 | 0.367 | Diuretic | 0.367 0.015 CID_70500973 | CID_70500973 | |
| 0.204 | 0.09 | 0.204 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.131 | 0.018 | 0.131 | Raf kinase C inhibitor | |||
| 0.115 | 0.004 | 0.115 | Dihydroorotate oxidase inhibitor | |||
| 0.126 | 0.015 | 0.126 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 CID_70500973 | ||
| 0.135 | 0.025 | 0.138 | Carbonic anhydrase XIII inhibitor | 0.138 0.024 CID_70500973 | CID_70500973 | |
| 0.127 | 0.017 | 0.127 | Aminopeptidase I inhibitor | |||
| 0.145 | 0.036 | 0.285 | DNA repair enzyme inhibitor | 0.285 0.005 CID_70500973 | CID_70500973 | |
| 0.127 | 0.019 | 0.127 | Glutathione S-transferase inhibitor | 0.074 0.072 CID_70500973 | ||
| 0.113 | 0.005 | 0.113 | MAP kinase kinase 7 inhibitor | |||
| 0.133 | 0.025 | 0.133 | Protein kinase C zeta inhibitor | |||
| 0.114 | 0.007 | 0.114 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.116 | 0.01 | 0.116 | CC chemokine 5 receptor agonist | |||
| 0.126 | 0.02 | 0.19 | Phosphodiesterase 6D inhibitor | 0.19 0.005 CID_70500973 | CID_70500973 | |
| 0.14 | 0.035 | 0.418 | AMP-activated protein kinase stimulant | 0.418 0.004 CID_70500973 | CID_70500973 | |
| 0.114 | 0.009 | 0.114 | NMDA receptor subunit 3B antagonist | |||
| 0.11 | 0.006 | 0.11 | Glutamate (mGluR7) antagonist | |||
| 0.119 | 0.016 | 0.119 | Carbamoyl phosphate synthetase inhibitor | 0.066 0.037 CID_70500973 | ||
| 0.15 | 0.046 | 0.15 | Cathepsin H inhibitor | |||
| 0.147 | 0.045 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.126 | 0.025 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.11 | 0.01 | 0.11 | Protein kinase C beta inhibitor | |||
| 0.107 | 0.007 | 0.107 | Exportin-1 inhibitor | |||
| 0.109 | 0.009 | 0.175 | Carbonic anhydrase XIV inhibitor | 0.175 0.005 CID_70500973 | CID_70500973 | |
| 0.125 | 0.025 | 0.125 | CYP2A6 inhibitor | |||
| 0.118 | 0.02 | 0.118 | Peroxisome proliferator-activated receptor gamma agonist | 0.08 0.04 CID_70500973 | ||
| 0.118 | 0.021 | 0.147 | ATPase (Vacuolar H+) inhibitor | 0.147 0.008 CID_70500973 | CID_70500973 | |
| 0.135 | 0.038 | 0.135 | Transcription factor STAT6 inhibitor | |||
| 0.138 | 0.042 | 0.138 | MAO B inhibitor | |||
| 0.112 | 0.017 | 0.112 | Argininosuccinate synthase inhibitor | 0.071 0.029 CID_70500973 | ||
| 0.106 | 0.011 | 0.106 | Phospholipase D inhibitor | |||
| 0.099 | 0.005 | 0.099 | Urate transporter 1 inhibitor | |||
| 0.113 | 0.019 | 0.113 | Aromatase inhibitor | |||
| 0.145 | 0.051 | 0.145 | Anesthetic local | |||
| 0.176 | 0.083 | 0.557 | Hepatoprotectant | 0.557 0.005 CID_70500973 | CID_70500973 | |
| 0.097 | 0.005 | 0.097 | Liver X receptor alpha agonist | |||
| 0.105 | 0.013 | 0.105 | Potassium channel (ATP-sensitive) blocker | |||
| 0.112 | 0.02 | 0.112 | Leukotriene synthesis inhibitor | |||
| 0.145 | 0.054 | 0.145 | MAP kinase kinase inhibitor | |||
| 0.099 | 0.009 | 0.099 | NMDA receptor subunit 3A antagonist | |||
| 0.103 | 0.013 | 0.103 | NMDA 2A receptor antagonist | |||
| 0.199 | 0.11 | 0.517 | Tumour necrosis factor alpha release inhibitor | 0.517 0.012 CID_70500973 | CID_70500973 | |
| 0.111 | 0.022 | 0.143 | Histone deacetylase SIRT1 stimulant | 0.143 0.01 CID_70500973 | CID_70500973 | |
| 0.111 | 0.022 | 0.143 | Histone deacetylase stimulant | 0.143 0.01 CID_70500973 | CID_70500973 | |
| 0.127 | 0.038 | 0.127 | Urease inhibitor | |||
| 0.111 | 0.022 | 0.111 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 CID_70500973 | ||
| 0.104 | 0.016 | 0.104 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.099 0.017 CID_70500973 | ||
| 0.116 | 0.028 | 0.116 | Cathepsin G inhibitor | |||
| 0.111 | 0.023 | 0.131 | Na+ K+ transporting ATPase inhibitor | 0.131 0.011 CID_70500973 | CID_70500973 | |
| 0.149 | 0.061 | 0.151 | Alkaline phosphatase inhibitor | 0.151 0.059 CID_70500973 | CID_70500973 | |
| 0.113 | 0.026 | 0.113 | NMDA 2 receptor antagonist | |||
| 0.101 | 0.016 | 0.101 | Acyl-CoA dehydrogenase inhibitor | 0.052 0.041 CID_70500973 | ||
| 0.153 | 0.071 | 0.153 | Acetylcholine M1 receptor antagonist | |||
| 0.097 | 0.015 | 0.115 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.115 0.012 CID_70500973 | CID_70500973 | |
| 0.094 | 0.013 | 0.094 | Fatty acid synthase inhibitor | |||
| 0.187 | 0.106 | 0.187 | Dyrk kinase inhibitor | |||
| 0.091 | 0.011 | 0.091 | MDM2 inhibitor | |||
| 0.097 | 0.017 | 0.097 | Xanthine dehydrogenase inhibitor | |||
| 0.093 | 0.013 | 0.093 | Heat shock protein 90 beta antagonist | |||
| 0.128 | 0.049 | 0.128 | Falcipain 3 inhibitor | |||
| 0.09 | 0.011 | 0.09 | Cyclin D1 inhibitor | |||
| 0.116 | 0.039 | 0.116 | MAP kinase kinase 1 inhibitor | |||
| 0.081 | 0.004 | 0.081 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.092 | 0.014 | 0.092 | Glutamate (mGluR6) antagonist | 0.062 0.059 CID_70500973 | ||
| 0.094 | 0.017 | 0.094 | Carbonic anhydrase VB inhibitor | |||
| 0.088 | 0.011 | 0.088 | Cyclin B2 inhibitor | |||
| 0.095 | 0.019 | 0.095 | Maillard reaction inhibitor | |||
| 0.084 | 0.008 | 0.125 | Glucose-6-phosphate isomerase inhibitor | 0.125 0.003 CID_70500973 | CID_70500973 | |
| 0.095 | 0.019 | 0.095 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.088 | 0.012 | 0.088 | Sphingosine kinase 2 inhibitor | |||
| 0.108 | 0.032 | 0.108 | Adrenaline agonist | |||
| 0.09 | 0.015 | 0.09 | Cyclin B1 inhibitor | |||
| 0.091 | 0.017 | 0.091 | Beta 3 adrenoreceptor antagonist | |||
| 0.089 | 0.016 | 0.089 | Transcription factor AP-1 inhibitor | 0.085 0.018 CID_70500973 | ||
| 0.1 | 0.027 | 0.1 | Carbonic anhydrase V inhibitor | |||
| 0.084 | 0.012 | 0.084 | 5-Alpha-reductase inhibitor | 0.032 0.031 CID_70500973 | ||
| 0.122 | 0.05 | 0.122 | Nav1.4 sodium channel blocker | |||
| 0.097 | 0.026 | 0.097 | Dopamine D1 antagonist | |||
| 0.125 | 0.054 | 0.125 | Caspase 3 inhibitor | |||
| 0.254 | 0.184 | 0.254 | Transcription factor inhibitor | |||
| 0.111 | 0.04 | 0.111 | NMDA receptor antagonist | |||
| 0.097 | 0.026 | 0.097 | Carbonic anhydrase VA inhibitor | |||
| 0.084 | 0.014 | 0.137 | Leukotriene B4 antagonist | 0.137 0.006 CID_70500973 | CID_70500973 | |
| 0.078 | 0.009 | 0.078 | Adenylate cyclase 1 inhibitor | |||
| 0.103 | 0.034 | 0.103 | Inducible nitric-oxide synthase inhibitor | |||
| 0.078 | 0.01 | 0.078 | Ryanodine receptor antagonist | |||
| 0.075 | 0.006 | 0.075 | Dopamine beta hydroxylase inhibitor | |||
| 0.106 | 0.037 | 0.106 | Platelet growth factor antagonist | |||
| 0.169 | 0.1 | 0.169 | I kappa B kinase epsilon inhibitor | |||
| 0.113 | 0.046 | 0.113 | Sphingomyelinase inhibitor | 0.104 0.055 CID_70500973 | ||
| 0.264 | 0.197 | 0.849 | Cyclophilin D inhibitor | 0.849 0.005 CID_70500973 | CID_70500973 | |
| 0.108 | 0.041 | 0.108 | ABCA1 expression enhancer | |||
| 0.111 | 0.045 | 0.111 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.088 | 0.023 | 0.088 | NMDA receptor glycine site agonist | |||
| 0.074 | 0.009 | 0.074 | Estrogen-related receptor alpha antagonist | |||
| 0.074 | 0.011 | 0.074 | CXC chemokine 1 receptor antagonist | |||
| 0.098 | 0.034 | 0.147 | Glycine receptor antagonist | 0.147 0.008 CID_70500973 | CID_70500973 | |
| 0.116 | 0.052 | 0.116 | Check point kinase 2 inhibitor | |||
| 0.136 | 0.072 | 0.136 | Toll-Like receptor 9 antagonist | |||
| 0.068 | 0.005 | 0.068 | Liver X receptor beta antagonist | |||
| 0.089 | 0.027 | 0.089 | Leukotriene antagonist | 0.082 0.03 CID_70500973 | ||
| 0.086 | 0.023 | 0.086 | Beta adrenoreceptor antagonist | |||
| 0.092 | 0.03 | 0.092 | Carbonic anhydrase inhibitor | 0.087 0.032 CID_70500973 | ||
| 0.068 | 0.007 | 0.068 | Liver X receptor beta agonist | |||
| 0.077 | 0.017 | 0.077 | Cyclin B inhibitor | |||
| 0.072 | 0.012 | 0.072 | Leukotriene C antagonist | |||
| 0.079 | 0.019 | 0.079 | Autotaxin inhibitor | |||
| 0.064 | 0.004 | 0.064 | Estrogen-related receptor beta antagonist | |||
| 0.087 | 0.026 | 0.087 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.074 | 0.014 | 0.127 | Glucose-6-phosphate translocase inhibitor | 0.127 0.004 CID_70500973 | CID_70500973 | |
| 0.079 | 0.02 | 0.079 | Cannabinoid CB2 receptor antagonist | |||
| 0.078 | 0.019 | 0.078 | Transcription factor RelA inhibitor | |||
| 0.088 | 0.03 | 0.088 | Potassium channel large-conductance Ca-activated activator | |||
| 0.217 | 0.158 | 0.217 | Thioredoxin glutathione reductase inhibitor | |||
| 0.061 | 0.003 | 0.061 | Elastase 2B inhibitor | 0.034 0.015 CID_70500973 | ||
| 0.061 | 0.003 | 0.061 | Elastase 3A inhibitor | 0.034 0.015 CID_70500973 | ||
| 0.061 | 0.003 | 0.061 | Elastase 3B inhibitor | 0.034 0.015 CID_70500973 | ||
| 0.067 | 0.009 | 0.067 | Geranyltranstransferase inhibitor | |||
| 0.121 | 0.064 | 0.121 | Proteasome inhibitor | |||
| 0.139 | 0.082 | 0.45 | Hemostatic | 0.45 0.005 CID_70500973 | CID_70500973 | |
| 0.083 | 0.027 | 0.083 | NMDA receptor agonist | |||
| 0.07 | 0.014 | 0.07 | Pregnane X receptor antagonist | |||
| 0.071 | 0.016 | 0.071 | Topoisomerase II beta inhibitor | 0.051 0.031 CID_70500973 | ||
| 0.072 | 0.017 | 0.072 | Beta 2 adrenoreceptor agonist | |||
| 0.07 | 0.017 | 0.196 | Alpha-mannosidase inhibitor | 0.196 0.003 CID_70500973 | CID_70500973 | |
| 0.062 | 0.009 | 0.062 | Sirtuin 2 inhibitor | |||
| 0.067 | 0.015 | 0.067 | Squalene epoxidase inhibitor | |||
| 0.058 | 0.007 | 0.058 | Retinoid X receptor antagonist | |||
| 0.068 | 0.016 | 0.068 | Potassium channel Kv1.3 blocker | |||
| 0.062 | 0.01 | 0.069 | Guanylate cyclase inhibitor | 0.069 0.005 CID_70500973 | CID_70500973 | |
| 0.093 | 0.043 | 0.093 | Histamine H2 receptor antagonist | |||
| 0.066 | 0.015 | 0.066 | Immunoglobulin Fc receptor antagonist | |||
| 0.06 | 0.011 | 0.06 | Alpha 1d adrenoreceptor agonist | |||
| 0.072 | 0.023 | 0.072 | Sphingosine kinase inhibitor | |||
| 0.118 | 0.069 | 0.291 | Topoisomerase II inhibitor | 0.291 0.019 CID_70500973 | CID_70500973 | |
| 0.075 | 0.027 | 0.075 | Androgen agonist | |||
| 0.053 | 0.005 | 0.053 | Protein kinase C beta II inhibitor | |||
| 0.075 | 0.027 | 0.075 | Carbonic anhydrase II inhibitor | 0.06 0.035 CID_70500973 | ||
| 0.062 | 0.015 | 0.062 | Cholesterol esterase inhibitor | |||
| 0.083 | 0.036 | 0.083 | MAP kinase 7 inhibitor | |||
| 0.05 | 0.003 | 0.05 | Estrogen-related receptor gamma antagonist | |||
| 0.055 | 0.009 | 0.055 | Glutamate (mGluR8) agonist | |||
| 0.056 | 0.009 | 0.056 | Kainate receptor agonist | |||
| 0.082 | 0.037 | 0.082 | Vanilloid 4 agonist | |||
| 0.055 | 0.01 | 0.055 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.097 | 0.052 | 0.097 | Potassium channel activator | |||
| 0.096 | 0.051 | 0.096 | Opioid antagonist | |||
| 0.13 | 0.085 | 0.13 | CDC-like kinase 1 inhibitor | |||
| 0.109 | 0.064 | 0.135 | Multidrug resistance-associated protein 1 inhibitor | 0.135 0.034 CID_70500973 | CID_70500973 | |
| 0.061 | 0.016 | 0.061 | Oxytocin agonist | |||
| 0.061 | 0.016 | 0.21 | Mannosidase inhibitor | 0.21 0.003 CID_70500973 | CID_70500973 | |
| 0.056 | 0.011 | 0.056 | Fumarate hydratase inhibitor | 0.039 0.02 CID_70500973 | ||
| 0.061 | 0.018 | 0.061 | Leukocyte elastase inhibitor | |||
| 0.065 | 0.021 | 0.065 | Thromboxane synthase inhibitor | |||
| 0.048 | 0.005 | 0.048 | Thyroid hormone agonist | |||
| 0.145 | 0.102 | 0.145 | LIM domain kinase 1 inhibitor | |||
| 0.101 | 0.058 | 0.101 | Glutamate (mGluR7) agonist | |||
| 0.105 | 0.062 | 0.185 | Toll-Like receptor 4 antagonist | 0.185 0.009 CID_70500973 | CID_70500973 | |
| 0.047 | 0.005 | 0.047 | Protein kinase C beta I inhibitor | 0.038 0.012 CID_70500973 | ||
| 0.053 | 0.011 | 0.053 | Potassium channel Kv1.1 blocker | |||
| 0.133 | 0.091 | 0.133 | Thiol protease inhibitor | |||
| 0.079 | 0.037 | 0.079 | Opioid delta receptor antagonist | |||
| 0.073 | 0.031 | 0.073 | NMDA 2C receptor antagonist | |||
| 0.081 | 0.038 | 0.081 | Prostaglandin-E synthase inhibitor | |||
| 0.103 | 0.062 | 0.103 | Gastric antisecretory | |||
| 0.049 | 0.007 | 0.049 | Retinoid X alpha receptor antagonist | |||
| 0.064 | 0.023 | 0.064 | Lysine-specific demethylase 1A inhibitor | |||
| 0.062 | 0.022 | 0.062 | Prolyl endopeptidase inhibitor | |||
| 0.049 | 0.008 | 0.063 | Uridine phosphorylase inhibitor | 0.063 0.005 CID_70500973 | CID_70500973 | |
| 0.078 | 0.038 | 0.078 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.133 | 0.093 | 0.133 | Neuropeptide Y1 antagonist | |||
| 0.053 | 0.013 | 0.053 | Retinoid X alpha receptor agonist | |||
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.049 | 0.009 | 0.049 | CF transmembrane conductance regulator antagonist | |||
| 0.068 | 0.028 | 0.068 | Beta 1 adrenoreceptor antagonist | |||
| 0.063 | 0.024 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 CID_70500973 | CID_70500973 | |
| 0.076 | 0.037 | 0.076 | Protein kinase C alpha inhibitor | |||
| 0.071 | 0.032 | 0.071 | Adenosine A1 receptor antagonist | |||
| 0.05 | 0.012 | 0.05 | MAP3K5 inhibitor | |||
| 0.113 | 0.075 | 0.223 | Alkylator | 0.223 0.021 CID_70500973 | CID_70500973 | |
| 0.06 | 0.022 | 0.245 | Heparanase inhibitor | 0.245 0.002 CID_70500973 | CID_70500973 | |
| 0.048 | 0.01 | 0.048 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.137 | 0.099 | 0.137 | Growth hormone agonist | |||
| 0.063 | 0.025 | 0.063 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.044 | 0.007 | 0.044 | Glutamate (mGluR3) agonist | |||
| 0.088 | 0.051 | 0.088 | mTOR complex 2 inhibitor | |||
| 0.044 | 0.008 | 0.044 | 5-Alpha-reductase 2 inhibitor | |||
| 0.048 | 0.012 | 0.048 | Leukotriene C4 antagonist | |||
| 0.108 | 0.071 | 0.108 | Nav1.5 sodium channel blocker | |||
| 0.046 | 0.009 | 0.046 | ATP citrate lysase inhibitor | |||
| 0.052 | 0.016 | 0.052 | Dihydropteroate synthase inhibitor | |||
| 0.048 | 0.012 | 0.048 | Integrin alpha2 antagonist | |||
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | |||
| 0.066 | 0.031 | 0.066 | Heme oxygenase stimulant | |||
| 0.037 | 0.002 | 0.037 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.01 CID_70500973 | ||
| 0.058 | 0.022 | 0.058 | Potassium channel (Inward rectifier) activator | |||
| 0.087 | 0.053 | 0.087 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.059 | 0.025 | 0.059 | Beta 2 adrenoreceptor antagonist | |||
| 0.051 | 0.017 | 0.051 | Retinoid X receptor agonist | |||
| 0.055 | 0.022 | 0.055 | Potassium channel (ATP-sensitive) activator | |||
| 0.048 | 0.015 | 0.048 | Nicotinic acid receptor agonist | |||
| 0.041 | 0.009 | 0.041 | Liver X receptor alpha antagonist | |||
| 0.097 | 0.065 | 0.097 | Nitric-oxide synthase inhibitor | |||
| 0.068 | 0.036 | 0.068 | Cannabinoid CB1 receptor antagonist | |||
| 0.166 | 0.135 | 0.39 | Vasodilator | 0.39 0.025 CID_70500973 | CID_70500973 | |
| 0.064 | 0.032 | 0.064 | Carbonic anhydrase I inhibitor | 0.056 0.038 CID_70500973 | ||
| 0.082 | 0.051 | 0.196 | Topoisomerase II alpha inhibitor | 0.196 0.015 CID_70500973 | CID_70500973 | |
| 0.054 | 0.024 | 0.054 | Oleamide hydrolase inhibitor | |||
| 0.083 | 0.053 | 0.083 | Opioid kappa receptor antagonist | |||
| 0.061 | 0.031 | 0.061 | Ornithine carbamoyltransferase inhibitor | |||
| 0.051 | 0.022 | 0.051 | Liver X receptor agonist | |||
| 0.047 | 0.018 | 0.047 | Histone deacetylase 9 inhibitor | |||
| 0.045 | 0.016 | 0.045 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.033 | 0.004 | 0.033 | Nicotinic acid receptor 1 antagonist | |||
| 0.044 | 0.015 | 0.044 | Vanilloid 3 antagonist | |||
| 0.146 | 0.117 | 0.146 | Death-associated protein kinase 2 inhibitor | |||
| 0.099 | 0.071 | 0.213 | Mediator release inhibitor | 0.213 0.013 CID_70500973 | CID_70500973 | |
| 0.12 | 0.091 | 0.12 | Histone deacetylase SIRT1 inhibitor | |||
| 0.036 | 0.008 | 0.036 | 5-Alpha-reductase 1 inhibitor | |||
| 0.05 | 0.022 | 0.05 | Histone deacetylase 8 inhibitor | |||
| 0.04 | 0.012 | 0.04 | Cyclin E2 inhibitor | |||
| 0.071 | 0.043 | 0.071 | Sirtuin 1 inhibitor | |||
| 0.044 | 0.016 | 0.044 | Glutamate (mGluR3) antagonist | |||
| 0.083 | 0.055 | 0.083 | Caspase 7 inhibitor | |||
| 0.046 | 0.02 | 0.046 | Heme oxygenase inhibitor | |||
| 0.035 | 0.008 | 0.035 | Integrin alpha2beta1 antagonist | |||
| 0.075 | 0.049 | 0.075 | Lipase inhibitor | |||
| 0.051 | 0.024 | 0.051 | Carbonic anhydrase IV inhibitor | |||
| 0.04 | 0.014 | 0.04 | Liver X receptor antagonist | |||
| 0.055 | 0.029 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.064 | 0.038 | 0.064 | Phosphodiesterase 1C inhibitor | |||
| 0.067 | 0.041 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.085 | 0.059 | 0.085 | Calcium antagonist | |||
| 0.033 | 0.007 | 0.033 | Acid ceramidase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Estrogen-related receptor gamma agonist | |||
| 0.048 | 0.022 | 0.048 | Beta adrenoreceptor agonist | |||
| 0.04 | 0.014 | 0.04 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.045 | 0.02 | 0.045 | Histone deacetylase 7 inhibitor | |||
| 0.03 | 0.004 | 0.03 | Retinoid X beta receptor antagonist | |||
| 0.033 | 0.008 | 0.033 | Glutamate (mGluR1a) agonist | |||
| 0.072 | 0.047 | 0.072 | Cannabinoid receptor antagonist | |||
| 0.036 | 0.011 | 0.036 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.123 | 0.098 | 0.123 | Cytidine deaminase inhibitor | |||
| 0.07 | 0.046 | 0.07 | Opioid mu receptor antagonist | |||
| 0.032 | 0.008 | 0.053 | Vanilloid 2 agonist | 0.053 0.003 CID_70500973 | CID_70500973 | |
| 0.065 | 0.041 | 0.065 | Calcium channel P-type blocker | |||
| 0.109 | 0.085 | 0.109 | MAP kinase 12 inhibitor | |||
| 0.046 | 0.023 | 0.046 | Nerve growth factor antagonist | |||
| 0.028 | 0.004 | 0.044 | Antibiotic Anthracycline-like | 0.044 0.002 CID_70500973 | CID_70500973 | |
| 0.038 | 0.015 | 0.038 | Protein kinase (CK2) beta inhibitor | |||
| 0.096 | 0.074 | 0.269 | Topoisomerase I inhibitor | 0.269 0.014 CID_70500973 | CID_70500973 | |
| 0.037 | 0.015 | 0.037 | Cholesterol ester transfer protein antagonist | |||
| 0.032 | 0.011 | 0.032 | Nicotinic acid receptor 2 antagonist | |||
| 0.059 | 0.038 | 0.079 | Carbonic anhydrase IX inhibitor | 0.079 0.028 CID_70500973 | CID_70500973 | |
| 0.065 | 0.045 | 0.065 | Aryl hydrocarbon receptor antagonist | |||
| 0.059 | 0.039 | 0.059 | Glutamate (mGluR1) antagonist | |||
| 0.053 | 0.033 | 0.053 | Thromboxane A2 antagonist | |||
| 0.056 | 0.036 | 0.056 | Glucosylceramidase inhibitor | |||
| 0.075 | 0.055 | 0.075 | Analgesic, opioid | |||
| 0.069 | 0.05 | 0.069 | Amidase inhibitor | |||
| 0.046 | 0.027 | 0.046 | AICAR transformylase inhibitor | |||
| 0.075 | 0.057 | 0.075 | Somatostatin 1 agonist | |||
| 0.03 | 0.012 | 0.03 | Hedgehog signaling activator | |||
| 0.031 | 0.013 | 0.031 | CXC chemokine 2 receptor antagonist | |||
| 0.143 | 0.124 | 0.143 | Catenin beta inhibitor | |||
| 0.104 | 0.086 | 0.104 | Acetylcholine muscarinic antagonist | |||
| 0.043 | 0.025 | 0.043 | Sphingosine kinase 1 inhibitor | |||
| 0.032 | 0.014 | 0.032 | Purinergic P2Y15 antagonist | |||
| 0.055 | 0.037 | 0.055 | Epithelial sodium channel blocker | |||
| 0.058 | 0.041 | 0.058 | Botulinum neurotoxin type A inhibitor | |||
| 0.117 | 0.1 | 0.117 | Nav1.6 sodium channel blocker | |||
| 0.03 | 0.013 | 0.121 | Sodium/glucose cotransporter 2 inhibitor | 0.121 0.002 CID_70500973 | CID_70500973 | |
| 0.038 | 0.021 | 0.038 | Phosphoglycerate kinase inhibitor | |||
| 0.054 | 0.037 | 0.054 | Thromboxane antagonist | |||
| 0.058 | 0.041 | 0.058 | CDK4/cyclin D1 inhibitor | |||
| 0.069 | 0.052 | 0.069 | Benzodiazepine agonist | |||
| 0.072 | 0.056 | 0.08 | Phosphodiesterase VI inhibitor | 0.08 0.041 CID_70500973 | CID_70500973 | |
| 0.048 | 0.032 | 0.048 | Adenosine deaminase inhibitor | 0.044 0.036 CID_70500973 | ||
| 0.058 | 0.042 | 0.058 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.027 | 0.011 | 0.027 | Prostaglandin F2 alpha agonist | |||
| 0.034 | 0.018 | 0.034 | Peptide deformylase inhibitor | |||
| 0.063 | 0.047 | 0.063 | Neutrophil collagenase inhibitor | |||
| 0.071 | 0.056 | 0.071 | Adenosine A3 receptor antagonist | |||
| 0.029 | 0.014 | 0.029 | Retinoid X gamma receptor antagonist | |||
| 0.061 | 0.047 | 0.061 | 5 Hydroxytryptamine 3 agonist | |||
| 0.224 | 0.21 | 0.224 | Analgesic | |||
| 0.048 | 0.035 | 0.048 | Plasminogen activator inhibitor antagonist | |||
| 0.044 | 0.03 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.028 | 0.014 | 0.114 | Sodium/glucose cotransporter inhibitor | 0.114 0.002 CID_70500973 | CID_70500973 | |
| 0.073 | 0.06 | 0.073 | Metalloproteinase-2 inhibitor | |||
| 0.122 | 0.108 | 0.392 | Thrombolytic | 0.392 0.012 CID_70500973 | CID_70500973 | |
| 0.041 | 0.029 | 0.041 | CDK5/p25 inhibitor | |||
| 0.123 | 0.111 | 0.123 | Sigma receptor agonist | |||
| 0.02 | 0.007 | 0.02 | CC chemokine 9 receptor antagonist | |||
| 0.057 | 0.045 | 0.057 | Acetylcholine M3 receptor antagonist | |||
| 0.031 | 0.019 | 0.031 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.056 | 0.045 | 0.056 | CDK4/cyclin D inhibitor | |||
| 0.02 | 0.008 | 0.028 | Telomerase stimulant | 0.028 0.003 CID_70500973 | CID_70500973 | |
| 0.054 | 0.043 | 0.054 | 5 Hydroxytryptamine 7 agonist | |||
| 0.024 | 0.013 | 0.024 | Beta 1 adrenoreceptor agonist | |||
| 0.043 | 0.032 | 0.043 | Glutamate (mGluR4) antagonist | |||
| 0.048 | 0.037 | 0.048 | Bombesin 2 receptor antagonist | |||
| 0.035 | 0.025 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.036 0.024 CID_70500973 | CID_70500973 | |
| 0.1 | 0.089 | 0.132 | Beta amyloid protein antagonist | 0.132 0.056 CID_70500973 | CID_70500973 | |
| 0.013 | 0.002 | 0.013 | Insulin like growth factor 3 antagonist | |||
| 0.016 | 0.005 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.036 | 0.026 | 0.066 | Arginase inhibitor | 0.066 0.008 CID_70500973 | CID_70500973 | |
| 0.097 | 0.087 | 0.097 | MAP kinase 13 inhibitor | |||
| 0.024 | 0.013 | 0.024 | Estrone sulfatase inhibitor | |||
| 0.044 | 0.034 | 0.044 | Opioid mu receptor agonist | |||
| 0.034 | 0.024 | 0.034 | Free fatty acid receptor 1 antagonist | |||
| 0.044 | 0.035 | 0.044 | Carbonic anhydrase VII inhibitor | |||
| 0.033 | 0.023 | 0.033 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.078 | 0.068 | 0.078 | Antineoplastic alkaloid | |||
| 0.023 | 0.014 | 0.023 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.013 | 0.004 | 0.013 | Thyroid hormone beta agonist | |||
| 0.057 | 0.048 | 0.057 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha antagonist | |||
| 0.027 | 0.019 | 0.027 | Lysine carboxypeptidase inhibitor | |||
| 0.014 | 0.007 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.036 | 0.028 | 0.036 | Delayed rectifier potassium channel blocker | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.028 | 0.021 | 0.028 | CDK4/cyclin D3 inhibitor | |||
| 0.024 | 0.018 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.048 | 0.041 | 0.06 | Factor III inhibitor | 0.06 0.018 CID_70500973 | CID_70500973 | |
| 0.046 | 0.04 | 0.046 | Potassium channel (Inward rectifier) blocker | |||
| 0.109 | 0.103 | 0.109 | Toll-Like receptor antagonist | |||
| 0.052 | 0.046 | 0.052 | Dopamine uptake inhibitor | |||
| 0.018 | 0.012 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.049 | 0.043 | 0.049 | Vanilloid 2 antagonist | |||
| 0.072 | 0.066 | 0.098 | Interferon agonist | 0.098 0.031 CID_70500973 | CID_70500973 | |
| 0.046 | 0.041 | 0.092 | Carbonic anhydrase XII inhibitor | 0.092 0.021 CID_70500973 | CID_70500973 | |
| 0.06 | 0.054 | 0.079 | Interferon inducer | 0.079 0.025 CID_70500973 | CID_70500973 | |
| 0.026 | 0.021 | 0.026 | Leukotriene B4 receptor 1 antagonist | 0.024 0.023 CID_70500973 | ||
| 0.025 | 0.02 | 0.025 | Complement factor 1s inhibitor | |||
| 0.05 | 0.045 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.04 | 0.036 | 0.04 | Stearoyl-CoA desaturase inhibitor | |||
| 0.017 | 0.013 | 0.017 | Alpha 2a adrenoreceptor agonist | |||
| 0.027 | 0.023 | 0.027 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.022 | 0.019 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.015 CID_70500973 | CID_70500973 | |
| 0.022 | 0.018 | 0.022 | Isoleucine-tRNA ligase inhibitor | |||
| 0.025 | 0.022 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.038 | 0.035 | 0.038 | Thymidine kinase inhibitor | |||
| 0.049 | 0.046 | 0.049 | GABA receptor antagonist | |||
| 0.015 | 0.012 | 0.015 | NMDA receptor phencyclidine site antagonist | |||
| 0.007 | 0.005 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.02 | 0.017 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.041 | 0.04 | 0.041 | Thymidylate synthase inhibitor | |||
| 0.052 | 0.051 | 0.052 | Carbonic anhydrase stimulant | |||
| 0.014 | 0.012 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.04 | 0.039 | 0.04 | Dihydroorotase inhibitor | |||
| 0.089 | 0.087 | 0.089 | Alpha 2b adrenoreceptor antagonist | |||
| 0.052 | 0.05 | 0.052 | Cannabinoid CB1 receptor agonist | |||
| 0.031 | 0.029 | 0.031 | RNA-directed RNA polymerase inhibitor | |||
| 0.058 | 0.057 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.054 | 0.053 | 0.054 | CDK1/cyclin B inhibitor | |||
| 0.12 | 0.12 | 0.158 | CC chemokine 6 receptor antagonist | 0.158 0.014 CID_70500973 | CID_70500973 | |
| 0.013 | 0.017 | 0.041 | Ileal bile acid transport inhibitor | 0.041 0.004 CID_70500973 | CID_70500973 | |
| 0.008 | 0.013 | 0.012 | Purinergic P2Y2 agonist | 0.012 0.005 CID_70500973 | CID_70500973 | |
| 0.017 | 0.025 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 CID_70500973 | CID_70500973 | |
| 0.125 | 0.138 | 0.473 | Platelet adhesion inhibitor | 0.473 0.006 CID_70500973 | CID_70500973 | |
| 0.042 | 0.057 | 0.056 | Cytokine production stimulant | 0.056 0.018 CID_70500973 | CID_70500973 | |
| 0.016 | 0.035 | 0.028 | Dopamine D1 agonist | 0.028 0.01 CID_70500973 | CID_70500973 | |
| 0.039 | 0.062 | 0.124 | Factor IXa inhibitor | 0.124 0.005 CID_70500973 | CID_70500973 | |
| 0.053 | 0.075 | 0.122 | Neuraminidase (influenza) inhibitor | 0.122 0.011 CID_70500973 | CID_70500973 | |
| 0.013 | 0.039 | 0.022 | Corticosteroid-like | 0.022 0.013 CID_70500973 | CID_70500973 | |
| 0.048 | 0.079 | 0.073 | Lipocortins synthesis agonist | 0.073 0.019 CID_70500973 | CID_70500973 | |
| 0.027 | 0.062 | 0.1 | Phosphorylase inhibitor | 0.1 0.013 CID_70500973 | CID_70500973 | |
| 0.02 | 0.056 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 CID_70500973 | CID_70500973 | |
| 0.048 | 0.086 | 0.259 | Antineoplastic antibiotic | 0.259 0.013 CID_70500973 | CID_70500973 | |
| 0.036 | 0.083 | 0.463 | Selectin antagonist | 0.463 0.003 CID_70500973 | CID_70500973 | |
| 0.008 | 0.089 | 0.056 | Squalene synthetase inhibitor | 0.056 0.013 CID_70500973 | CID_70500973 | |
| 0.028 | 0.11 | 0.099 | Neuraminidase inhibitor | 0.099 0.016 CID_70500973 | CID_70500973 | |
| 0.011 | 0.102 | 0.071 | Protein 30S ribosomal subunit inhibitor | 0.071 0.005 CID_70500973 | CID_70500973 | |
| 0.149 | 0.241 | 0.349 | Angiogenesis inhibitor | 0.349 0.071 CID_70500973 | CID_70500973 | |
| 0.02 | 0.125 | 0.056 | Prostaglandin EP2 antagonist | 0.056 0.045 CID_70500973 | CID_70500973 | |
| 0.148 | 0.257 | 0.533 | Immunosuppressant | 0.533 0.024 CID_70500973 | CID_70500973 | |
| 0.023 | 0.136 | 0.053 | Microtubule stabilization | 0.053 0.023 CID_70500973 | CID_70500973 | |
| 0.002 | 0.116 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_70500973 | CID_70500973 | |
| 0.056 | 0.173 | 0.173 | Transcription factor NF kappa B stimulant | 0.173 0.012 CID_70500973 | CID_70500973 | |
| 0.027 | 0.147 | 0.082 | Nitric oxide donor | 0.082 0.02 CID_70500973 | CID_70500973 | |
| 0.019 | 0.164 | 0.092 | Antibiotic Aminoglycoside-like | 0.092 0.003 CID_70500973 | CID_70500973 | |
| 0.019 | 0.164 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 CID_70500973 | CID_70500973 | |
| 0.015 | 0.222 | 0.038 | Toll-Like receptor 4 agonist | 0.038 0.005 CID_70500973 | CID_70500973 | |
| 0.016 | 0.232 | 0.131 | Protein 50S ribosomal subunit inhibitor | 0.131 0.008 CID_70500973 | CID_70500973 | |
| 0.072 | 0.29 | 0.373 | Platelet antagonist | 0.373 0.033 CID_70500973 | CID_70500973 | |
| 0.039 | 0.258 | 0.212 | Cell adhesion molecule inhibitor | 0.212 0.009 CID_70500973 | CID_70500973 | |
| 0.03 | 0.286 | 0.132 | DNA intercalator | 0.132 0.051 CID_70500973 | CID_70500973 | |
| 0.047 | 0.31 | 0.363 | Cell adhesion inhibitor | 0.363 0.006 CID_70500973 | CID_70500973 | |
| 0.032 | 0.373 | 0.087 | Falcipain 2 inhibitor | 0.087 0.063 CID_70500973 | CID_70500973 | |
| 0.032 | 0.377 | 0.089 | Falcipain inhibitor | 0.089 0.064 CID_70500973 | CID_70500973 | |
| 0.052 | 0.399 | 0.294 | Insulin secretagoues | 0.294 0.013 CID_70500973 | CID_70500973 | |
| 0.005 | 0.358 | 0.028 | Motilin receptor agonist | 0.028 0.011 CID_70500973 | CID_70500973 | |
| 0.038 | 0.475 | 0.093 | T cell inhibitor | 0.093 0.033 CID_70500973 | CID_70500973 | |
| 0.004 | 0.461 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 CID_70500973 | CID_70500973 | |
| 0.05 | 0.527 | 0.253 | Antiobesity | 0.253 0.153 CID_70500973 | CID_70500973 | |
| 0.045 | 0.612 | 0.492 | Immunomodulator | 0.492 0.024 CID_70500973 | CID_70500973 | |
| 0.013 | 0.633 | 0.264 | Anticoagulant | 0.264 0.035 CID_70500973 | CID_70500973 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |